Palo Alto – August 30, 2026 – WCP is delighted to release the MedDevice Market Update, Q2 2026, authored by senior banker Juliesta Sylvester PhD, and by analyst Ted Celentino.
The report covers the following key points and more:
- Medical Device growth remains steady, supported by aging populations and continued investment in areas such as robotic surgery, minimally invasive procedures, and specialized surgical devices. The global medical devices market is estimated at approximately $605B in 2026.
- Strategic buyers drove Q2 2026 M&A, with 71 transactions, up 16% year over year, and strategics representing 79% of acquisitions. Danaher’s $9.9B acquisition of Masimo added AI-enabled patient monitoring and sensor capabilities, while Medtronic’s $585M acquisition of CathWorks expanded its interventional cardiology portfolio with AI-powered coronary artery disease analysis.
- Venture funding strengthened, reaching approximately $3.8B in Q2, up from $1.8B in Q2 2025, with capital flowing primarily to AI-enabled diagnostics, digital health, medical devices, and precision medicine.
- AI adoption is broadening across medical devices, moving beyond clinical decision support into evidence generation, workflow automation, and supply-chain forecasting. AI is also increasingly becoming an acquisition driver, as the Masimo and CathWorks transactions illustrate.
- Care continues to move outside the hospital, increasing demand for at-home diagnostics and clinical wearables, while regulatory changes—including the FDA’s QMSR, effective February 2026—are raising expectations for quality systems, lifecycle risk management, and product commercialization.
Get the report here:
Woodside Capital Partners is a leading corporate finance advisory firm for tech companies in M&A and financings in the $30M –$500M enterprise value segment. The firm has worked with extraordinary entrepreneurs and investors since 2001, providing ultra-personalized service to its clients. Our team has global vision and reach, and has completed hundreds of successful engagements. We have deep industry knowledge and extensive domain and transaction experience in these and other sectors: Artificial Intelligence, CyberSecurity, HR Tech, Digital Advertising and Marketing, Autonomous Vehicles, ADAS, Computer Vision, Aerospace and Defense, CloudTech, Enterprise Software, IT Services, Information Security, FinTech, Internet of Things, Networking / Infrastructure, Robotics, Semiconductors, Quantum, Energy Storage, Digital Health & Virtual Care, Diagnostic, Medical Devices & Precision Medicine, Healthcare IT & Data Analytics Platforms, AI & Automation in Clinical Decision Support, Revenue Cycle Management & Financial Ops, Behavioral & Mental Health Tech, Value-Based Care & Preventive/Wellness Platforms, Healthcare Infrastructure & Cybersecurity. Woodside Capital Partners is a specialist in cross-border transactions, and has extensive relationships among venture capitalists, private equity investors, and corporate executives from Global 1000 companies.
Questions? Please contact Juliesta Sylvester PhD, Managing Director, Woodside Capital Partners at jsylvester@woodsidecap.com.